Anti-CD62E antibody [UZ6]
4
(1 Review)
|
(9 Publications)
Rat Monoclonal CD62E antibody. Suitable for ICC/IF and reacts with Mouse samples. Cited in 9 publications.
View Alternative Names
CD62E, ELAM1, SELE, E-selectin, CD62 antigen-like family member E, Endothelial leukocyte adhesion molecule 1, Leukocyte-endothelial cell adhesion molecule 2, ELAM-1, LECAM2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CD62E antibody [UZ6] (AB2497)
CHO-cells transfected with E-Selectin stained wtih ab2497 at 1/500.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E-selectin facilitates leukocyte adhesion by binding specific carbohydrate ligands on the surface of circulating immune cells. This binding is critical in the cascade of events that leads to leukocyte extravasation into tissues. E-selectin does not work in isolation rather forming part of a complex interaction with other cell adhesion molecules such as P-selectin and L-selectin. These interactions ensure precise control of cellular traffic during inflammatory responses.
Pathways
CD62E engages in the inflammatory signaling pathways including the NF-kB pathway. This pathway modulates the expression of E-selectin in response to pro-inflammatory cytokines like interleukin-1 and tumor necrosis factor-alpha. CD62E interacts with integrins on leukocytes and has downstream effects on cellular processes involved in immune response. Its cooperation with proteins like ICAM-1 and VCAM-1 further integrates it into a network of adhesion molecules maintaining vascular stability and immune surveillance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 16:1447319 PubMed40124367
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 17:504-534 PubMed39962271
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2404661 PubMed39364760
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:1165 PubMed34621018
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular and cellular cardiology 150:91-100 PubMed33127387
2020
Applications
Unspecified application
Species
Unspecified reactive species
Annals of palliative medicine 9:2079-2089 PubMed32692224
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 120:115-125 PubMed30206961
2018
Applications
Unspecified application
Species
Unspecified reactive species
Science translational medicine 3:69ra12 PubMed21307302
2011
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 269:266-74 PubMed11570819
2001
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com